Gastro-oesophageal Reflux Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Children between 2 and 18 years old who have been diagnosed with Cystic Fibrosis (CF), confirmed either by a sweat test or by having 2 known CF-causing gene changes
- A parent or guardian (and the child if old enough) must be willing to sign a consent form agreeing to take part
Who may not be able to join:
- Anyone who does not want to take part in the study or is unwilling to sign the consent form
- Children who have been diagnosed by a stomach/digestive specialist with a severe form of acid reflux (a condition where stomach acid frequently flows back up into the food pipe)
- Children who score higher than 80 on something called the GSAS score, which is a tool used to measure digestive symptoms (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Shatha Yousef, Duke University Hospital
Phone: 919-684-8111
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Change from baseline in the mean GSAS score (only if GERD medication discontinued); Mean GSAS score in children with CF on GERD therapy; Mean GSAS score in children with CF not on GERD therapy
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.